Creative Hybrid Chemistry For a Better Tomorrow
Text Size :
Site Search
About the Company
Investor Relations
Business & Products
R&D
Sustainability
Top Message
See more
Three Reports of Sumitomo Chemical
Investors' Meeting for the Business Strategy (Agro & Life Solutions, ICT & Mobility Solutions)
FY2024 3rd Quarter Financial Results Conference Call
Establishment of RACTHERA, the Regenerative Medicine and Cell Therapy Business Joint Venture
Understanding the Sumitomo Chemical Story
IR News
Contact
